45722 Federal Register / Vol. 83, No. 175 / Monday, September 10, 2018 / Notices 

Description of Collection 

Title: Generic Clearance for the 

Collection of Qualitative Feedback on 

Agency Service Delivery. 

OMB Control Number: 2140–0019. 

STB Form Number: None. 

Type of Review: Reinstatement 

without change. 

Respondents: Customers and 

stakeholders of the Board. 

Number of Respondents, Frequency, 

Estimated Time per Response, and Total 

Burden Hours: A variety of instruments 

and platforms may be used to collect 

information from respondents. The 

estimated annual burden hours (277) are 

based on the number of collections we 

expect to conduct over the requested 

period for this clearance, as set forth in 

the table below. 

ESTIMATED ANNUAL REPORTING BURDEN

Type of collection Number of 

respondents 

Annual 

frequency per 

response 

Hours per 

response Total hours 

Focus Group .................................................................................................... 15 1 2 30 

Comment Card/Brief Survey ............................................................................ 200 2 .17 67 

Surveys ............................................................................................................ 150 2 .6 180

Needs and Uses: The proposed 

information collection activity provides 

a means to garner qualitative customer 

and stakeholder feedback in an efficient 

and timely manner, in accordance with 

the Administration’s commitment to 

improving service delivery. By 

qualitative feedback we mean 

information that provides useful 

insights on perceptions and opinions, 

but not statistical surveys that yield 

quantitative results that can be 

generalized to the population of study. 

This feedback will provide insights into 

customer or stakeholder perceptions, 

experiences, and expectations; provide 

an early warning with issues about how 

the Board provides service to the public; 

or focus attention on areas where 

communication, training, or changes in 

operations might improve delivery of 

products or services. These collections 

will allow for ongoing, collaborative, 

and actionable communications 

between the Board and its customers 

and stakeholders. They will also allow 

feedback to contribute directly to the 

improvement of program management. 

The solicitation of feedback will target 

areas such as: Timeliness, 

appropriateness, accuracy of 

information, courtesy, efficiency of 

service delivery, and resolution of 

issues with service delivery. Responses 

will be assessed to plan and inform 

efforts to improve or maintain the 

quality of service offered to the public. 

If this information is not collected, vital 

feedback from customers and 

stakeholders on the Board’s services 

will be unavailable. 

The Board will only process a 

collection under this generic clearance 

if it meets the following conditions: 

• The collections are voluntary; 

• The collections are low-burden for 

respondents (based on considerations of 

total burden hours, total number of 

respondents, or burden-hours per 

respondent) and are low-cost for both 

the respondents and the Federal 

Government; 

• The collections are noncontroversial and do not raise issues of 

concern to other Federal agencies; 

• Any collection is targeted to the 

solicitation of opinions from 

respondents who have experience with 

the program or may have experience 

with the program in the near future; 

• Personally identifiable information 

is collected only to the extent necessary 

and is not retained; 

• Information gathered is used only 

internally for general service 

improvement and program management 

purposes and not for release outside of 

the agency; 

• Information gathered is used for the 

purpose of substantially informing 

influential policy decisions; and 

• Information gathered will yield 

qualitative information, and the 

collections will not be designed or 

expected to yield statistically reliable 

results or used as though the results are 

generalizable to the population of study. 

Feedback collected under this generic 

clearance will provide useful 

information, but will not yield data that 

can be generalized to the overall 

population. Such data uses would 

require more rigorous designs than the 

collections covered by this notice. 

As a general matter, information 

collections will not result in any new 

system of records containing privacy 

information and will not ask questions 

of a sensitive nature, such as sexual 

behavior and attitudes, religious beliefs, 

and other matters that are commonly 

considered private. 

Under the PRA, a federal agency that 

conducts or sponsors a collection of 

information must display a currently 

valid OMB control number. A collection 

of information, which is defined in 44 

U.S.C. 3502(3) and 5 CFR 1320.3(c), 

includes agency requirements that 

persons submit reports, keep records, or 

provide information to the agency, third 

parties, or the public. Section 3507(b) of 

the PRA requires, concurrent with an 

agency’s submitting a collection to OMB 

for approval, a 30-day notice and 

comment period through publication in 

the Federal Register concerning each 

proposed collection of information. 

Comments submitted in response to 

this notice may be made available to the 

public by the Board. For this reason, 

please do not include in your comments 

information of a confidential nature, 

such as sensitive personal information 

or proprietary information. If you send 

an electronic comment (e-file or email), 

your email address is automatically 

captured and may be accessed if your 

comments are made public. Please note 

that responses to this public comment 

request containing any routine notice 

about the confidentiality of the 

communication will be treated as public 

comments that may be made available to 

the public notwithstanding the 

inclusion of the routine notice. 

Dated: September 5, 2018. 

Jeffrey Herzig, 

Clearance Clerk. 

[FR Doc. 2018–19510 Filed 9–7–18; 8:45 am] 

BILLING CODE 4915–01–P 

SURFACE TRANSPORTATION BOARD 

Release of Waybill Data 

The Surface Transportation Board has 

received a request from two professors 

that work for University of Oregon and 

Stanford University along with four 

researchers (WB18–29—8/31/18) for 

permission to use data from the Board’s 

1983–2017 Unmasked Carload Waybill 

Samples. A copy of this request may be 

obtained from the Board’s website under 

docket no. WB18–29. 

The waybill sample contains 

confidential railroad and shipper data; 

therefore, if any parties object to these 

requests, they should file their 


daltland on DSKBBV9HB2PROD with NOTICES
Federal Register / Vol. 83, No. 175 / Monday, September 10, 2018 / Notices 45723 

1See http://www.ecfr.gov/cgi-bin/text-idx?SID=

e47b48a9ea42dd67d999246e23d97970&mc=true&

node=pt49.5.391&rgn=div5#ap49.5.391_171.a and 

https://www.gpo.gov/fdsys/pkg/CFR-2015-title49- 

vol5/pdf/CFR-2015-title49-vol5-part391-appA.pdf. 

objections with the Director of the 

Board’s Office of Economics within 14 

calendar days of the date of this notice. 

The rules for release of waybill data are 

codified at 49 CFR 1244.9. 

Contact: Alexander Dusenberry, (202) 

245–0319. 

Aretha Laws-Byrum, 

Clearance Clerk. 

[FR Doc. 2018–19521 Filed 9–7–18; 8:45 am] 

BILLING CODE 4915–01–P 

DEPARTMENT OF TRANSPORTATION 

Federal Motor Carrier Safety 

Administration 

[FMCSA Docket No. FMCSA–2018–0053] 

Qualification of Drivers; Exemption 

Applications; Epilepsy and Seizure 

Disorders 

AGENCY: Federal Motor Carrier Safety 

Administration (FMCSA), DOT. 

ACTION: Notice of final disposition. 

SUMMARY: FMCSA announces its 

decision to exempt eight individuals 

from the requirement in the Federal 

Motor Carrier Safety Regulations 

(FMCSRs) that interstate commercial 

motor vehicle (CMV) drivers have ‘‘no 

established medical history or clinical 

diagnosis of epilepsy or any other 

condition which is likely to cause loss 

of consciousness or any loss of ability to 

control a CMV.’’ The exemptions enable 

these individuals who have had one or 

more seizures and are taking antiseizure medication to operate CMVs in 

interstate commerce. 

DATES: The exemptions were applicable 

on August 1, 2018. The exemptions 

expire on August 1, 2020. 

FOR FURTHER INFORMATION CONTACT: Ms. 

Christine A. Hydock, Chief, Medical 

Programs Division, (202) 366–4001, 

fmcsamedical@dot.gov, FMCSA, 

Department of Transportation, 1200 

New Jersey Avenue SE, Room W64–224, 

Washington, DC 20590–0001. Office 

hours are from 8:30 a.m. to 5 p.m., e.t., 

Monday through Friday, except Federal 

holidays. If you have questions 

regarding viewing or submitting 

material to the docket, contact Docket 

Services, telephone (202) 366–9826. 

SUPPLEMENTARY INFORMATION: 

I. Electronic Access 

You may see all the comments online 

through the Federal Document 

Management System (FDMS) at: http:// 

www.regulations.gov. 

Docket: For access to the docket to 

read background documents or 

comments, go to http://

www.regulations.gov and/or Room 

W12–140 on the ground level of the 

West Building, 1200 New Jersey Avenue 

SE, Washington, DC, between 9 a.m. and 

5 p.m., e.t., Monday through Friday, 

except Federal holidays. 

Privacy Act: In accordance with 5 

U.S.C. 553(c), DOT solicits comments 

from the public to better inform its 

rulemaking process. DOT posts these 

comments, without edit, including any 

personal information the commenter 

provides, to http://www.regulations.gov, 

as described in the system of records 

notice (DOT/ALL–14 FDMS), which can 

be reviewed at http://www.dot.gov/ 

privacy. 

II. Background 

On June 21, 2018, FMCSA published 

a notice announcing receipt of 

applications from eight individuals 

requesting an exemption from the 

epilepsy and seizure disorders 

prohibition in 49 CFR 391.41(b)(8) and 

requested comments from the public (83 

FR 28896). The public comment period 

ended on July 23, 2018, and six 

comments were received. 

FMCSA has evaluated the eligibility 

of these applicants and determined that 

granting exemptions to these 

individuals would achieve a level of 

safety equivalent to or greater than the 

level that would be achieved by 

complying with the current regulation 

49 CFR 391.41(b)(8). 

The physical qualification standard 

for drivers regarding epilepsy found in 

49 CFR 391.41(b)(8) states that a person 

is physically qualified to drive a CMV 

if that person has no established 

medical history or clinical diagnosis of 

epilepsy or any other condition which 

is likely to cause the loss of 

consciousness or any loss of ability to 

control a CMV. 

In addition to the regulations, FMCSA 

has published advisory criteria 1 to 

assist medical examiners in determining 

whether drivers with certain medical 

conditions are qualified to operate a 

CMV in interstate commerce. [49 CFR 

part 391, APPENDIX A TO PART 391— 

MEDICAL ADVISORY CRITERIA, 

section H. Epilepsy: § 391.41(b)(8), 

paragraphs 3, 4, and 5.] 

III. Discussion of Comments 

FMCSA received six comments in this 

proceeding. Four of these comments 

supported granted the exemptions. One 

commenter did not support granting 

these exemptions due to his or her 

concerns about these drivers refilling 

their medications while they are 

operating a CMVs on an interstate basis. 

Another commenter suggested that these 

applicants should provide complete 

medical histories and records and be 

incident free for at least two years. This 

commenter also stated his or her 

opinion that employers of drivers who 

have been issued an exemption be 

required to obtain additional accident 

liability insurance for these drivers. In 

reviewing these applications for 

exemptions, FMCSA evaluated the 

medical records of all eight applicants, 

obtained documentation of the treating 

physician’s support for granting the 

applicant an exemption, and 

determined that granting these 

exemptions would achieve an 

equivalent or greater level of safety than 

would be achieved without the 

exemption. FMCSA does not require 

employers to obtain additional 

insurance for drivers with medical 

exemptions. 

IV. Basis for Exemption Determination 

Under 49 U.S.C. 31136(e) and 

31315(b), FMCSA may grant an 

exemption from the epilepsy and 

seizure disorder prohibition in 49 CFR 

391.41(b)(8) if the exemption is likely to 

achieve an equivalent or greater level of 

safety than would be achieved without 

the exemption. The exemption allows 

the applicants to operate CMVs in 

interstate commerce. 

In reaching the decision to grant these 

exemption requests, FMCSA considered 

the 2007 recommendations of the 

Agency’s Medical Expert Panel (MEP). 

The January 15, 2013, Federal Register 

notice (78 FR 3069) provides the current 

MEP recommendations which is the 

criteria the Agency uses to grant seizure 

exemptions. 

The Agency’s decision regarding these 

exemption applications is based on an 

individualized assessment of each 

applicant’s medical information, 

including the root cause of the 

respective seizure(s) and medical 

information about the applicant’s 

seizure history, the length of time that 

has elapsed since the individual’s last 

seizure, the stability of each individual’s 

treatment regimen and the duration of 

time on or off of anti-seizure 

medication. In addition, the Agency 

reviewed the treating clinician’s 

medical opinion related to the ability of 

the driver to safely operate a CMV with 

a history of seizure and each applicant’s 

driving record found in the Commercial 

Driver’s License Information System 

(CDLIS) for commercial driver’s license 

(CDL) holders, and interstate and 


daltland on DSKBBV9HB2PROD with NOTICES